Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Bydureon BCise is a long-acting version of the GLP-1 agonist exenatide, used to help control blood sugar in people with type 2 diabetes. Bydureon BCise has been shown to reduce A1C by 1.5% to 1.9% ...